These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34425274)

  • 1. Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis.
    Barberio B; Savarino EV; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e923-e944. PubMed ID: 34425274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis.
    Barberio B; Savarino EV; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14279. PubMed ID: 34672052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Black CJ; Burr NE; Camilleri M; Earnest DL; Quigley EM; Moayyedi P; Houghton LA; Ford AC
    Gut; 2020 Jan; 69(1):74-82. PubMed ID: 30996042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    Qi Q; Zhang Y; Chen F; Zuo X; Li Y
    BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
    Black CJ; Burr NE; Quigley EMM; Moayyedi P; Houghton LA; Ford AC
    Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Andresen V; Montori VM; Keller J; West CP; Layer P; Camilleri M
    Clin Gastroenterol Hepatol; 2008 May; 6(5):545-55. PubMed ID: 18242143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.
    Nelson AD; Black CJ; Houghton LA; Lugo-Fagundo NS; Lacy BE; Ford AC
    Aliment Pharmacol Ther; 2021 Jul; 54(2):98-108. PubMed ID: 34114657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Bosman M; Elsenbruch S; Corsetti M; Tack J; Simrén M; Winkens B; Boumans T; Masclee A; Keszthelyi D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):459-473. PubMed ID: 33765447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation.
    Chang L; Chey WD; Drossman D; Losch-Beridon T; Wang M; Lichtlen P; Mareya S
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1114-1122. PubMed ID: 27669680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis.
    Zhao Q; Fang Y; Yan C; Gao J; Liu Z; Zhu H; Tang D; Wang D
    Z Gastroenterol; 2022 Jun; 60(6):970-977. PubMed ID: 34215016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
    World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
    Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
    Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.
    Nee J; Salley K; Ludwig AG; Sommers T; Ballou S; Takazawa E; Duehren S; Singh P; Iturrino J; Katon J; Lee HN; Rangan V; Lembo AJ
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00110. PubMed ID: 31800542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.